VIDEO

FindCenter AddIcon

Opening Plenary: Rick Doblin, Amanda Feilding & Beatriz Labate

By Amanda Feilding — 2017

Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.

01:11:17 min

13:25

Can Ketamine and MDMA Treat Trauma?

This weeks video looks at the effects of MDMA/ecstasy and ketamine as a treatment option for ptsd. The biological mechanisms involved in these drugs for ptsd as well as depression/anxiety are mentioned, as well as the therapeutic benefits and research in the area.

FindCenter AddIcon
06:25

Sanjay Gupta MD: Psychedelic Medicine Gets a Closer Look

Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.

FindCenter AddIcon
28:25

Phil Wolfson & Julane Andries: MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness

Phil Wolfson, MD, and Julane Andries, MFT MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness

FindCenter AddIcon
01:04:12

MDMA & Psychedelics for Treating Depression & PTSD- M.A.P.S- ( Mark Haden & Arcane Bear )

We are excited to bring you the executive director of MAPS- As we dive into the world of psychedelics and their uses in the world of medicine.

FindCenter AddIcon
07:41

Roland Griffiths: Psilocybin Research for Anxiety & Psychological Distress

FindCenter AddIcon
15:59

The Science of Psilocybin and Its Use to Relieve Suffering

Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.

FindCenter AddIcon
01:32:51

Dr. Robin Carhart-Harris: Can Psychedelics Cure Depression?

Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.

FindCenter AddIcon
29:53

Dr Robin Carhart-Harris - A Unified Model of the Brain Action of Psychedelics

REBUS and the Anarchic Brain: A Unified Model of the Brain Action of Psychedelics Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.

FindCenter AddIcon
02:01

Two-Minute Neuroscience: MDMA

MDMA, better known as ecstasy, molly, or one of a number of other street names, is a stimulant drug with unique prosocial effects. In this video, I discuss the current understanding of how MDMA acts on the brain to produce its effects.

FindCenter AddIcon
01:20:04

Paul Stamets at the Psilocybin Summit 2020 - Psilocybin Mushrooms & Their Emergent Medicines

Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.

FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research